Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan Institutional has received final US Food and Drug Administration (FDA) approval for its abbreviated new drug application for Tranexamic Acid Injection, 100 mg/mL.
Subscribe to our email newsletter
Tranexamic Acid Injection, 100 mg/mL are packaged in 1,000 mg/10 mL Single-dose Vials.
This product is the generic version of Pharmacia & Upjohn’s Cyklokapron Injection.
Tranexamic Acid Injection is indicated for short-term use in patients with hemophilia to reduce or prevent hemorrhage during and following oral surgery.